India Likely To Face Vaccine Shortage For Next Few Months: Serum Institute’s CEO Adar PoonawallaAdar Poonawalla (Twitter)

Chief executive of Pune-based vaccine maker Serum Institute of India (SII), Adar Poonawalla has said that India is likely to face a shortage of COVID-19 vaccines for the next few months, reports Economic Times.

Though SII is presently pursuing an expansion of its capacity to produce Covishield vaccines, Poonawalla said that it had not expanded the capacity earlier due to lack of orders. He said, "There were no orders, we did not think we needed to make more than 1 billion doses a year."

With the expansion of capacity presently underway, SII is expected to increase its production of Covishield vaccines from the present 60-70 million doses a month to 100 million doses from July.

Since the beginning of the nationwide vaccination drive on 16 January, India has so far given at least one dose of either Covishield or Bharat Biotech's Covaxin COVID-19 vaccines to over 157 million people who make up about 12 per cent of the population. Over two per cent of the population has received two doses so far.

An Appeal...

Dear Reader,

As you are no doubt aware, Swarajya is a media product that is directly dependent on support from its readers in the form of subscriptions. We do not have the muscle and backing of a large media conglomerate nor are we playing for the large advertisement sweep-stake.

Our business model is you and your subscription. And in challenging times like these, we need your support now more than ever.

We deliver over 10 - 15 high quality articles with expert insights and views. From 7AM in the morning to 10PM late night we operate to ensure you, the reader, get to see what is just right.

Becoming a Patron or a subscriber for as little as Rs 1200/year is the best way you can support our efforts.

Become A Patron
Become A Subscriber